Clinical Significance of PD-L1-Positive Extracellular Vesicles in Patients with Oral Cancer

被引：0
|
作者：
Seki, Yuki [1 ,2 ]
Yoshida, Ryoji [2 ]
Kawahara, Kenta [2 ]
Hirayama, Masatoshi [2 ]
Takahashi, Nozomu [2 ]
Inoue, Junki [3 ]
Shinohara, Kosuke [1 ,2 ]
Nakayama, Hideki [3 ]
机构：
[1] Kumamoto Univ, Grad Sch Med Sci, Kumamoto, Japan
[2] Kumamoto Univ, Fac Life Sci, Dept Oral & Maxillofac Surg, Kumamoto, Japan
[3] Kumamoto Univ, Dept Oral & Maxillofacial Surg, Kumamoto, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2200
引用
收藏
页码：1408 / 1408
页数：1
相关论文
共 50 条
  • [21] Histopathological and Genomic Features of PD-L1-Positive Prostate Carcinoma
    Lin, Douglas
    Ye, Huihui
    Parimi, Vamsi
    Lechpammer, Mirna
    Mata, Douglas
    Decker, Brennan
    Hiemenz, Matthew
    Elvin, Julia
    Ross, Jeffrey
    Huang, Richard
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 625 - 625
  • [22] Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
    Mehnert, Janice M.
    Varga, Andrea
    Brose, Marcia S.
    Aggarwal, Rahul R.
    Lin, Chia-Chi
    Prawira, Amy
    de Braud, Filippo
    Tamura, Kenji
    Doi, Toshihiko
    Piha-Paul, Sarina A.
    Gilbert, Jill
    Saraf, Sanatan
    Thanigaimani, Pradeep
    Cheng, Jonathan D.
    Keam, Bhumsuk
    BMC CANCER, 2019, 19 (1)
  • [23] Histopathological and Genomic Features of PD-L1-Positive Prostate Carcinoma
    Lin, Douglas
    Ye, Huihui
    Parimi, Vamsi
    Lechpammer, Mirna
    Mata, Douglas
    Decker, Brennan
    Hiemenz, Matthew
    Elvin, Julia
    Ross, Jeffrey
    Huang, Richard
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 625 - 625
  • [24] Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer
    Chen, Tzu-Yi
    Mihalopoulos, Meredith
    Zuluaga, Laura
    Rich, Jordan
    Ganta, Teja
    Mehrazin, Reza
    Tsao, Che-Kai
    Tewari, Ash
    Gonzalez-Kozlova, Edgar
    Badani, Ketan
    Dogra, Navneet
    Kyprianou, Natasha
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [25] Spatial Profile of Tumor Microenvironment in PD-L1-Negative and PD-L1-Positive Triple-Negative Breast Cancer
    Tashireva, Liubov A.
    Kalinchuk, Anna Yu.
    Gerashchenko, Tatiana S.
    Menyailo, Maksim
    Khozyainova, Anna
    Denisov, Evgeniy V.
    Perelmuter, Vladimir M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [26] Immune Landscape in PD-L1-positive and TROP2-positive Triple-Negative Breast Cancer
    Gyorffy, Balazs
    Santarpia, Libero
    CANCER RESEARCH, 2024, 84 (09)
  • [27] The clinical significance of PD-L1 in colorectal cancer
    Ntomi, Vasileia
    Foukas, Periklis
    Papaconstantinou, Dimitrios
    Antonopoulou, Ioanna
    Pikoulis, Andreas
    Panagiotides, Ioannis
    Pikoulis, Emmanouil
    Syrigos, Konstantinos
    ONCOLOGY REPORTS, 2021, 45 (06)
  • [28] PD-L1 expression in endometrial carcinomas: which tumours are more likely to be PD-L1-positive?
    Amarin, J. Z.
    Mansour, R.
    Al-Ghnimat, S.
    Lataifeh, I.
    Jaradat, I.
    Abdeen, G.
    Otay, L.
    Shatnawi, Q.
    Abu Sheikha, A.
    Dayyat, A.
    Abuhijla, F.
    El Khaldi, M.
    Al-Hussaini, M.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S31 - S31
  • [29] Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
    Reck, Martin
    Rodriguez-Abreu, Delvys
    Robinson, Andrew G.
    Hui, Rina
    Csoszi, Tibor
    Fulop, Andrea
    Gottfried, Maya
    Peled, Nir
    Tafreshi, Ali
    Cuffe, Sinead
    O'Brien, Mary
    Rao, Suman
    Hotta, Katsuyuki
    Leiby, Melanie A.
    Lubiniecki, Gregory M.
    Shentu, Yue
    Rangwala, Reshma
    Brahmer, Julie R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1823 - 1833
  • [30] Immunological Characterization of PD-L1-Positive Non-Small Cell Lung Cancer Cells
    Igarashi, Tomoyuki
    Hanaoka, Jun
    Teramoto, Koji
    Daigo, Yataro
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S600 - S600
12345